These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8383621)

  • 21. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
    Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
    Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of the acyl-CoA: cholesterol O-acyltransferase inhibitor, CL 277082, on cholesteryl ester accumulation in rabbit macrophage-rich granulomas and hepatic tissue.
    Kelley JL; Suenram CA; Rozek MM; Schaffer SA; Schwartz CJ
    Biochim Biophys Acta; 1988 May; 960(1):83-90. PubMed ID: 3358947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesterol-lowering effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol diet-fed rats and rabbits.
    Azuma Y; Kawasaki T; Ikemoto K; Obata K; Ohno K; Sajiki N; Yamada T; Yamasaki M; Nobuhara Y
    Jpn J Pharmacol; 1998 Nov; 78(3):355-64. PubMed ID: 9869270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic effects in beagle dogs administered atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, for 2 years.
    Walsh KM; Rothwell CE
    Toxicol Pathol; 1999; 27(4):395-401. PubMed ID: 10485819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
    Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
    Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional differences in cholesterol ester hydrolase and acyl-coenzyme-A/cholesterol acyltransferase between the outer and inner zones of the guinea pig adrenal cortex.
    Nishikawa T; Mikami K; Saito Y; Tamura Y; Yoshida S
    Endocrinology; 1988 Mar; 122(3):877-83. PubMed ID: 3342756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet.
    Junquero D; Bruniquel F; N'Guyen X; Autin JM; Patoiseau JF; Degryse AD; Colpaert FC; Delhon A
    Atherosclerosis; 2001 Mar; 155(1):131-42. PubMed ID: 11223434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits.
    Tanaka H; Ohtsuka I; Kogushi M; Kimura T; Fujimori T; Saeki T; Hayashi K; Kobayashi H; Yamada T; Hiyoshi H
    Atherosclerosis; 1994 Jun; 107(2):187-201. PubMed ID: 7980693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TMP-153, a novel ACAT inhibitor, lowers plasma cholesterol through its hepatic action in golden hamsters.
    Sugiyama Y; Odaka H; Itokawa S; Ishikawa E; Tomari Y; Ikeda H
    Atherosclerosis; 1995 Nov; 118(1):145-53. PubMed ID: 8579624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subchronic toxicity of atorvastatin, a hydroxymethylglutaryl-coenzyme A reductase inhibitor, in beagle dogs.
    Walsh KM; Albassam MA; Clarke DE
    Toxicol Pathol; 1996; 24(4):468-76. PubMed ID: 8864188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of monatepil maleate on acyl-CoA:cholesterol acyltransferase activity in the liver of cholesterol-fed Japanese monkeys.
    Sumiya T; Ikeno A; Kato H; Fujitani B; Masuda Y; Hosoki K; Miyazaki M
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):779-85. PubMed ID: 9234833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 2. Identification and structure-activity relationships of a novel series of N-alkyl-N-(heteroaryl-substituted benzyl)-N'-arylureas.
    Tanaka A; Terasawa T; Hagihara H; Sakuma Y; Ishibe N; Sawada M; Takasugi H; Tanaka H
    J Med Chem; 1998 Jun; 41(13):2390-410. PubMed ID: 9632372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RP 64477: a potent inhibitor of acyl-coenzyme A:cholesterol O-acyltransferase with low systemic bioavailability.
    Bello AA; Bright C; Burton BJ; Bush RC; Casey JH; Dron DI; Facchini V; Joannou PP; Parrott DP; Riddell D; Roberts SA; Williams RJ
    Biochem Pharmacol; 1996 Feb; 51(4):413-21. PubMed ID: 8619885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereological and functional investigations on isolated adrenocortical cells: zona fasciculata/reticularis cells of chronically ACTH-treated rats.
    Andreis PG; Rebuffat P; Belloni AS; Neri G; Cavallini L; Gottardo G; Mazzocchi G; Coi A; Malendowicz LK; Nussdorfer GG
    Cell Tissue Res; 1989 Oct; 258(1):43-51. PubMed ID: 2553263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of E5324, a novel inhibitor of acyl-CoA:cholesterol acyltransferase, on cholesteryl ester synthesis and accumulation in macrophages.
    Kogushi M; Tanaka H; Kobayashi H; Yamada T; Ohtsuka I; Kimura T; Saito I
    Jpn J Pharmacol; 1995 Jun; 68(2):191-9. PubMed ID: 7563976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and pharmacology of aortic-selective acyl-CoA: Cholesterol O-acyltransferase (ACAT/SOAT) inhibitors.
    Shibuya K; Kawamine K; Miura T; Ozaki C; Edano T; Mizuno K; Yoshinaka Y; Tsunenari Y
    Bioorg Med Chem; 2018 Aug; 26(14):4001-4013. PubMed ID: 29945757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syntheses and pharmacological activities of novel optically active inhibitors of acyl-CoA: cholesterol O-acyltransferase: EAB-309 ((R)-N-2-(1,3-benzodioxol-4-yl)heptyl-N'-2,6-diisopropylphenylurea) and its enantiomer.
    Sekiya T; Inoue S; Shirasaka T; Miyajima C; Okushima H; Suzuki K; Kawai M; Mitsuka M; Umezu K
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):586-91. PubMed ID: 8004704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypolipidemic and antiatherosclerotic effects of a novel ACAT inhibitor, HL-004, in stroke-prone spontaneously hypertensive rats.
    Murakami S; Nara Y; Yamori Y
    Exp Mol Pathol; 1995 Aug; 63(1):23-32. PubMed ID: 8759051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential antiatherosclerotic agents. 5. An acyl-CoA:cholesterol O-acyltransferase inhibitor with hypocholesterolemic activity.
    DeVries VG; Schaffer SA; Largis EE; Dutia MD; Wang CH; Bloom JD; Katocs AS
    J Med Chem; 1986 Jul; 29(7):1131-3. PubMed ID: 3100794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.